VVOS - Vivos Therapeutics Inc. (VVOS) CEO Kirk Huntsman on Q2 2021 Results - Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q2 2021 Earnings Conference Call August 12, 2021 05:00 PM ET Company Participants Edward Loew - Investor Relations Officer Kirk Huntsman - Chief Executive Officer Brad Amman - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Scott Henry - ROTH Capital Presentation Operator Good day everyone, and welcome to the Vivos Therapeutics Second Quarter 2021 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow management’s remarks. This conference call is being recorded and a replay of today’s call will be available on the Investor Relations section of Vivo's website and will remain posted there for the next 30 days. I will now hand the call over to Mr. Edward Loew, Vivos' Investor Relations Officer for introductions and the reading of the safe harbor statement. Please go ahead sir. Edward Loew Thank you, operator. Hello, everyone,
For further details see:
Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q2 2021 Results - Earnings Call Transcript